The biology of IL-15: implications for cancer therapy and the treatment of autoimmune disorders (Q34658294)

3 August 2017

title

The biology of IL-15: implications for cancer therapy and the treatment of autoimmune disorders (English)

1 reference

3 August 2017

Thomas A Waldmann

1

1 reference

3 August 2017

publication date

1 December 2013

1 reference

The journal of investigative dermatology. Symposium proceedings

3 August 2017

published in

1 reference

3 August 2017

volume

16

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

S28-30

1 reference

Increased serum soluble IL-15Rα levels in T-cell large granular lymphocyte leukemia

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJIDSYMP.2013.8

7 January 2021

Induction of the IL-9 gene by HTLV-I Tax stimulates the spontaneous proliferation of primary adult T-cell leukemia cells by a paracrine mechanism

1 reference

https://api.crossref.org/works/10.1038%2FJIDSYMP.2013.8

7 January 2021

IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells

1 reference

https://api.crossref.org/works/10.1038%2FJIDSYMP.2013.8

7 January 2021

CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP

1 reference

https://api.crossref.org/works/10.1038%2FJIDSYMP.2013.8

7 January 2021

IL-15 administered by continuous infusion to rhesus macaques induces massive expansion of CD8+ T effector memory population in peripheral blood

1 reference

https://api.crossref.org/works/10.1038%2FJIDSYMP.2013.8

7 January 2021

The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design

1 reference

https://api.crossref.org/works/10.1038%2FJIDSYMP.2013.8

7 January 2021

Phase 1 trial of IL-15 trans presentation blockade using humanized Mikβ1 mAb in patients with T-cell large granular lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FJIDSYMP.2013.8

7 January 2021

Safety (toxicity), pharmacokinetics, immunogenicity, and impact on elements of the normal immune system of recombinant human IL-15 in rhesus macaques

1 reference

https://api.crossref.org/works/10.1038%2FJIDSYMP.2013.8

7 January 2021

Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease

1 reference

https://api.crossref.org/works/10.1038%2FJIDSYMP.2013.8

7 January 2021

Identifiers

DOI

10.1038/JIDSYMP.2013.8

1 reference

3 August 2017

1 reference